[1]Pridgen,LendonN.;Shilcrat,S.C.;Lantos,I.[TetrahedronLetters,1984,vol.25,#27,p.2835-2838]
[1]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2011/82077,2011,A1Locationinpatent:Page/Pagecolumn215-216
4675-18-7
14383-51-8 | Nortropine, HCl | AA001IDN | MFCD01711246
1441-97-0 | 1-(2-(Methylthio)phenyl)ethanone | AA001IVD | MFCD11553501
1444-94-6 | 1,2-Cyclohexanedicarboximide | AA001JDX | MFCD00035737
14464-68-7 | L-3-Trifluoromethylphenylalanine | AA001JTG | MFCD00044945
144889-50-9 | L-Cysteine, N-acetyl-S-(3,4-dihydroxybutyl)- | AA001K7T | MFCD03701113
145122-56-1 | 4,7-Diaza-spiro[2.5]octane dihydrochloride | AA001KHU | MFCD11506235
1484-84-0 | 2-Piperidineethanol | AA001KTV | MFCD00005989
148819-94-7 | Carboxy-ptio, potassium salt | AA001L50 | MFCD00216153
1492-52-0 | Z-Ser(tos)-ome | AA001LE8 | MFCD00237368
149506-35-4 | 1,3-Dimethyl 2-(4-bromophenyl)propanedioate | AA001LPP | MFCD06204131